IL-15RαFc superagonist SHR-1501 with or without bacille Calmette Guerin (BCG) for high-risk non-muscle invasive bladder cancer (NMIBC): A phase 1/2 study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Yuke Chen, Hailong Hu, Shan Liang, Jianming Guo, Wei Xue, Lianhua Zhang, Haitao Niu, Yu Cao, Xiang Wang, Hang Huang, Hongqian Guo, Zengjun Wang, Lei Li, Danfeng Xu, Xin Xie, Xianfeng Zhou, Jiaqin Lin, Mingming Zhang, Denghui Gao, Zhisong He
Institutions: Peking University First Hospital, Second Hospital of Tianjin Medical University, Fudan University, Zhongshan Hospital, Shanghai Jiao Tong University, Renji Hospital, Affiliated Hospital of Qingdao University, Shanghai First People's Hospital, First Affiliated Hospital of Wenzhou Medical University, Nanjing Drum Tower Hospital, Jiangsu Province Hospital, Nanjing Medical University, First Affiliated Hospital of Xi'an Jiaotong University, Ruijin Hospital, Jiangsu Hengrui Medicine (China)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410818669